Please provide your email address to receive an email when new articles are posted on . Good vascular access continues to be a cornerstone of optimal hemodialysis (HD) for patients with end-stage ...

Intravascular catheter-related bloodstream infections are a major cause of morbidity and mortality in the United States. In the intensive care unit (ICU), the rate of central venous catheter ...

A catheter dressing incorporating a chlorhexidine gluconate gel pad may reduce the presence of microorganisms at insertion and suture sites, according to recently published data. “The use of [central ...

A major difference between children and adults is that in pediatric patients, age and, particularly, weight and length of the patient are decisive factors determining the choice of CVC type and ...

Patients undergoing bone marrow transplantation require long-term venous access for the administration of medication, blood products, parenteral hyperalimentation and for blood sampling. Central ...

DefenCath is intended for instillation into central venous catheters only. DefenCath ® (taurolidine and heparin) catheter lock solution is now available for inpatient use to reduce the incidence of ...

Long-term use of a topical antibiotic application at central venous catheter (CVC) exit sites in hemodialysis (HD) patients may result in a sustained decrease in all CVC-related infections, according ...

In this prospective study, we assessed the incidence of central venous catheter (CVC)-related thrombosis in haematopoietic stem cell transplant (HSCT) recipients. We determined the contribution of ...

The cumulative incidence of CVC-related infection was 24% (25 of 105 patients). Clinically manifest thrombosis occurred in 13 (12%) of 105 patients. In patients with CVC-related infection, the risk of ...